Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Candel Therapeutics, Inc. | Chief Financial Officer | Common Stock | 202K | $182K | $0.90 | Nov 28, 2023 | Direct |
TScan Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 750K | Feb 1, 2024 | Direct | ||
Candel Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 90K | Apr 28, 2023 | Direct | ||
Acer Therapeutics Inc. | Director | Stock Option (right to buy) | 20K | Mar 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Jan 29, 2024 | 0 | $0 | 3 | Feb 2, 2024 | Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Nov 28, 2023 | 1 | -$18.1K | 4 | Nov 30, 2023 | Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Nov 26, 2023 | 1 | $0 | 4 | Nov 28, 2023 | Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Apr 28, 2023 | 1 | $0 | 4 | May 2, 2023 | Chief Financial Officer |
ACER | Acer Therapeutics Inc. | Mar 14, 2023 | 1 | $0 | 4 | Mar 16, 2023 | Director |
CADL | Candel Therapeutics, Inc. | Dec 8, 2022 | 2 | $10K | 4 | Dec 12, 2022 | Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Nov 28, 2022 | 1 | $0 | 4 | Nov 30, 2022 | Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Sep 21, 2022 | 1 | $0 | 4 | Sep 23, 2022 | Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Sep 21, 2022 | 0 | $0 | 3 | Sep 23, 2022 | Chief Financial Officer |
ACER | Acer Therapeutics Inc. | Jan 14, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Director |